Acinar Atrophy
Acinar Atrophy - Related Videos
06:36
Primary Acinar Cell Isolation: A Method to Isolate Acinar Cells from Mouse Pancreas
0 Views •
2023
This video describes the technique used for isolating pancreatic acinar cells--exocrine cells--containing a variety of digestive enzymes. Primary acinar cells are useful in the ex vivo study of acinar-to-ductal metaplasia (ADM)--an early event in developing pancreatic cancer.
03:21
Acinar-to-Ductal Metaplasia Induction: A Method to Study Acinar Cell to Ductal Cell Differentiation in 3D Ex Vivo Culture
0 Views •
2023
This video describes the technique of differentiating pancreatic acinar cells to ductal cells in ex vivo 3D culture. This helps to understand the mechanisms regulating the acinar-to-ductal metaplasia (ADM), a key process in the early development of pancreatic cancer.
09:39
A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways
0 Views •
Cited by 17 •
2016
Soft-lithography was utilized to produce a representative true-scale model of pulmonary alveolated airways that expand and contract periodically, mimicking physiological breathing motion. This platform recreates respiratory acinar flows on a chip, and is anticipated to facilitate experimental investigation of inhaled aerosol dynamics and deposition in the pulmonary acinus.
01:21
Detection of Brain Atrophy by Hematoxylin and Eosin Staining
0 Views •
2025
To detect brain atrophy, begin with slides carrying the deparaffinized brain sections from neurodegenerative mouse models at various ages.
14:39
A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice
0 Views •
2026
This study developed a simplified method to efficiently extract functional primary islets and acinar cells from the mouse pancreas, offering a valuable tool for studying intercellular communication in the pathogenesis of Acute Pancreatitis-Induced Diabetes.
FAQs
Persistent inflammation, duct obstruction, and direct tissue injury can progressively disrupt acinar cells rather than causing only a temporary reduction in secretion. As cells disappear, fibrotic tissue may occupy the affected areas. This structural progression links chronic pancreatic damage with declining digestive-enzyme output and helps explain why functional consequences may worsen as the underlying disease continues.
Fibrotic replacement matters because it reduces the amount of tissue available for enzyme secretion. The resulting decline can produce pancreatic exocrine insufficiency, meaning the gland cannot supply adequate digestive enzymes. In clinical reasoning, this connects a microscopic structural change with downstream digestive problems, particularly malabsorption, and indicates that the tissue injury has functional consequences rather than being an incidental finding.
It should be interpreted as a tissue response or outcome of ongoing damage, not as a synonym for every cause. Inflammation, obstruction, or injury can initiate acinar loss, while the atrophy signals that structural damage has accumulated. This distinction helps clinicians investigate the underlying disorder rather than treating the histological change as an isolated diagnosis.
Histological specimens and imaging can reveal abnormalities associated with acinar loss, supporting evaluation of chronic pancreatitis and other gland disorders. Histology provides tissue-level evidence, while imaging contributes to assessment of organ structure in the clinical setting. These findings can help relate structural abnormalities to impaired exocrine function and guide further evaluation of the affected gland.
Reduced enzyme production limits digestive capacity, so nutrients may not be processed adequately and malabsorption can result. In a patient with pancreatic disease, identifying acinar loss provides a structural explanation for related digestive symptoms rather than viewing them as nonspecific complaints. This connection also supports assessment for pancreatic exocrine insufficiency and consideration of treatment directed at the missing digestive function.
Recognition prompts attention to both the functional consequences and the underlying cause. Enzyme replacement may address reduced digestive-enzyme availability, while treatment of the underlying disease aims to control the process producing tissue injury. The finding therefore contributes to a broader management plan: address digestive effects, investigate chronic pancreatitis or another gland disorder, and interpret symptoms in light of structural damage.